%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/14737167.2020.1751613
en
Evaluation of the Cost-Utility of the York Faecal Calprotectin Care Pathway
Hayden Holmes
Jessica McMaster
Heather Davies
Victoria Vaines
James Turvill
Taylor & Francis
Expert Review of Pharmacoeconomics & Outcomes Research, 2020. doi:10.1080/14737167.2020.1751613
Diagnostic
Fecal calprotectin
general practice
health-related quality of life
inflammatory bowel disease
irritable bowel syndrome
Journal
Expert Review of Pharmacoeconomics & Outcomes Research
© 2020 Informa UK Limited, trading as Taylor & Francis Group
1473-7167
1744-8379
00
00
1
8
10.1080/14737167.2020.1751613
https://doi.org/10.1080/14737167.2020.1751613
VoR
2020-04-18T12:55:14+05:30
Arbortext Advanced Print Publisher 11.0.3433/W Unicode
2020-04-20T01:15:04-07:00
2020-04-20T01:15:04-07:00
Diagnostic; Fecal calprotectin; general practice; health-related quality of life; inflammatory bowel disease; irritable bowel syndrome
iText 4.2.0 by 1T3XT
uuid:a6528d84-2327-4bef-ad52-4efc3d2cd78c
uuid:e7fd6dd9-f952-4f46-94dc-1336cfb03aae
2020-04-19truewww.tandfonline.com10.1080/14737167.2020.1751613www.tandfonline.comtrue2020-04-1910.1080/14737167.2020.1751613
endstream
endobj
4 0 obj
<>stream
xYɎ]5ݿx$-XE6>U*wxɦպ{=kT3ܠ'A[x Zw|J&q+w